The Bayh-Dole Coalition

Join The Bayh-Dole Coalition for a webinar on 12/6 from 1-2 PM ET, titled "Unleashing America’s Entrepreneurs: The Bayh-Dole Formula for Economic Prosperity." We will discuss?how the Bayh-Dole Act plays a crucial role in bolstering the U.S. economy and how we can protect our innovation ecosystem from ongoing and future threats. The webinar will be moderated by Executive Director Joseph Allen and feature the following expert panelists: - Almesha L. Campbell, Ph.D., RTTP, HonNAI, assistant vice president for Research and Economic Development at Jackson State University - Walter Copan, vice president for Research and Technology Transfer at the Colorado School of Mines - Brian Darmody, chief strategy officer at the Association of University Research Parks - Franck Journoud, senior director of Technology Policy at the National Association of Manufacturers We hope to see you there! Learn more and register at the link below: https://lnkd.in/dQCn5GWs #BayhDole #techtransfer #science #health #medicine #research #technology #innovation #patents #IP #licensing #policy #webinar

READ: Joseph Allen, executive director of The Bayh-Dole Coalition, was recently featured in an Inside Health Policy article discussing the march-in framework. While some lawmakers are pushing for the finalization of this misguided legislation, Joe explains why the policy should not be implemented -- and why Bayh-Dole must remain intact. "The Bayh-Dole Coalition's Joe Allen, who helped craft the Bayh-Dole Act that houses the government's right to "march-in" on the patents of an invention developed using U.S. funding, says the Biden administration's lack of urgency to finalize the framework floated last year shows the administration might not believe in its potential either." "The fact that the Biden administration had this thing for eight months, they rolled it out with the White House touting it as an important tool to lower drug prices, and then they never pulled the trigger . . . We heard rumors it was going to come out imminently. It never did. And I don't know the reason, but my speculation is that the Biden administration realized this thing is a loser..." "Allen and the Bayh Dole Coalition, as well as others opposed to price being made an official factor to consider when determining whether to use march-in rights, have also said the draft framework is not equipped to help lower drug prices because most prescription drugs were not developed with federal funding. Finalizing the proposal would hinder innovation for drugs and other inventions across different business sectors, since such a change would also impact them, they say." Read the full article: https://lnkd.in/e5aSjimG #BayhDole #techtransfer #science #health #medicine #research #technology #innovation #patents #IP #licensing #policy

I am pleased to share this short (3 minute) YouTube video released today about the American Innovator award I received with 4 others, in September 2024 in Washington DC https://lnkd.in/gnpvfVmq

The Bayh-Dole Coalition recently sent a letter to the Senate Judiciary Committee expressing our support for three bills scheduled for review during the committee markup on November 14, 2024: S.2220, the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act; S.2140, the Patent Eligibility Restoration Act (PERA); and S.4713, the Inventor Diversity for Economic Advancement (IDEA) Act. If passed, they will strengthen our patent system, which is the foundation of the Bayh-Dole Act that has done so much to enhance U.S. innovation at the time we need it most. Our letter highlights the significance of these bills and their potential to advance America's technological and economic leadership. "The PREVAIL Act, PERA, and the IDEA Act would enable key reforms to bolster U.S. innovation and reinforce the patent protections that undergird the world-class technology transfer system established by the Bayh-Dole Act. To address the ongoing challenges facing inventors and safeguard the future of American innovation, we sincerely urge [legislators] to preserve the integrity of these acts in their current form during the upcoming committee mark-up session." "These three pieces of legislation would significantly enhance clarity within our current patent system, bolster patent protections for American innovators, and supply essential data to ensure we leverage our nation's full creative potential. [Legislators'] stewardship of these important reforms is crucial to the success of America's university research enterprise and to our continued economic and technological prosperity." Read the full letter here: https://lnkd.in/eSUAFTJv #BayhDole #PREVAIL #PERA #IDEA #letter #policy #law #legislation #Congress #research #technology #techtransfer #patents

READ: Steven Infanti, member of The Bayh-Dole Coalition, recently published a piece in PennLive.com about how the Bayh-Dole Act paved the way for the successful inventors of today -- and how undermining it would hinder the bright minds of tomorrow. "The Penn Center for Innovation continues to bring groundbreaking ideas to life under Bayh-Dole. Over a billion people have benefited from the medical and other discoveries licensed through the Center." "The Bayh-Dole Act catalyzed the entrepreneurial spirit nationwide. From 1996 to 2020, the legislation was responsible for up to $1.9 trillion in industrial output, 6.5 million jobs, and 17,000 startups." "Though the Bayh-Dole Act allows the federal government to “march in” and relicense patents under specified circumstances, none authorizes doing so based on price. Bayh-Dole’s bipartisan authors expressly rejected using march-in rights to obtain lower prices." "Further, studies indicate that the Biden proposal would have no meaningful effect on drug prices. However, the new framework would pull the rug from under current and future inventors." Read the full op-ed: https://lnkd.in/gThMkj3p #BayhDole #techtransfer #science #health #medicine #research #technology #innovation #patents #IP #licensing #policy #Pennsylvania

READ: Joseph Allen, executive director of The Bayh-Dole Coalition, recently published an article in IPWatchdog, Inc. discussing the efforts to preserve Bayh-Dole and how this year has been a "win" for our U.S. innovation ecosystem. "As we sort through the results of the recent election, one thing that should be noted is what didn’t happen. The Biden-Harris Administration, despite intense pressure from its progressive allies, never finalized the pending march in guidelines." "The draft?guidelines, which issued late last year, were an attempt to misuse the landmark Bayh-Dole Act so the government could micro-manage the price of products based on federally-funded inventions." "[We] now have the opportunity to present a positive message to the new Administration and Congress touting the benefits to the economy and?public well-being because of our unique, decentralized system of public/private sector R&D alliances." Read the full article below: https://lnkd.in/eEwwnxa5 #BayhDole #techtransfer #science #health #medicine #research #technology #innovation #patents #IP #licensing #policy

LISTEN: Joseph Allen, executive director of The Bayh-Dole Coalition, was recently featured in the Federal Newswire Lunch Hour podcast with Andrew Langer! The conversation highlights the legacy of the Bayh-Dole Act and how undermining it would threaten U.S.?innovation. "What Bayh-Dole says is... we want to give the incentives and authority for commercialization, but we also want to make sure people are making good faith efforts to use it." "If [the march-in framework] goes into place, it would undo the 44-year history of Bayh-Dole." "This whole claim has been, for 30 years now, that march-in rights will lower prices. So you've had a number of studies done looking at that theory, and what they found is: No, it won't." "People's lives depend on this." Watch the full interview below: https://lnkd.in/eBxMP5-T #BayhDole #policy #law #legislation #Congress #research #technology #techtransfer #patents #podcast

In September, we were so excited to share that Hong Hua, Professor at UArizona Wyant College of Optical Sciences, was honored by the The Bayh-Dole Coalition as one of five American "Faces of Innovation." The Coalition has released this highlight reel of the event. Check out the highlight reel to hear what Hong had to say about her honor! We're so proud of you, Hong! Thank you for your dedication and inspiring innovation:

The Bayh-Dole Coalition recently sent a letter to the Senate Judiciary Committee expressing our support for three bills scheduled for review during the committee markup on November 14, 2024: S.2220, the Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act; S.2140, the Patent Eligibility Restoration Act (PERA); and S.4713, the Inventor Diversity for Economic Advancement (IDEA) Act. If passed, they will strengthen our patent system, which is the foundation of the Bayh-Dole Act that has done so much to enhance U.S. innovation at the time we need it most. Our letter highlights the significance of these bills and their potential to advance America's technological and economic leadership. "The PREVAIL Act, PERA, and the IDEA Act would enable key reforms to bolster U.S. innovation and reinforce the patent protections that undergird the world-class technology transfer system established by the Bayh-Dole Act. To address the ongoing challenges facing inventors and safeguard the future of American innovation, we sincerely urge [legislators] to preserve the integrity of these acts in their current form during the upcoming committee mark-up session." "These three pieces of legislation would significantly enhance clarity within our current patent system, bolster patent protections for American innovators, and supply essential data to ensure we leverage our nation's full creative potential. [Legislators'] stewardship of these important reforms is crucial to the success of America's university research enterprise and to our continued economic and technological prosperity." Read the full letter here: https://lnkd.in/eSUAFTJv #BayhDole #PREVAIL #PERA #IDEA #letter #policy #law #legislation #Congress #research #technology #techtransfer #patents

READ: Recent research demonstrates that "march in" will have almost no impact on drug prices. Published in JAMA Health Forum, the study found: "The findings suggest that few drugs have solely march-in–eligible patents, so the overall effect of march-in on removing patent barriers to competition would be limited." "The results of this cross-sectional study suggest that the overall impact of exercising Bayh-Dole march-in rights on removing patent barriers to competition would be small... March-in rights are not relevant for most drugs." "If policymakers want to lower prices for a broader array of drugs, they should thus focus on other policies." Read the full study here: https://ja.ma/4eirhqp #BayhDole #study #policy #law #legislation #Congress #research #technology #techtransfer #science #medicine